ArticleEJVES vascular forum2025
Gender and Geographical Diversity in Authorship, Peer Reviewing, and Editorial Roles in the
Article in EJVES vascular forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Gender based disparities have been reported regarding principal investigator positions, authorship of medical published literature, reviewing roles, and representation in journal editorial boards. This study aimed to analyse gender and geographical differences in the authorship and editorial roles of the Methods: An observational retrospective study was performed of all consecutive submissions to EJVES VF between 2020 - 2023. Data were gathered on: first author's gender, first author's professional country, last author's gender, number of authors per submission, article type, and final editorial decision. Gender and professional country of external reviewers and editorial staff were also analysed, as well as performance indicators. The statistical analysis was descriptive and chi squared and Results: A total of 577 submitted papers were included. First authors were female (FFA) in 26.7% and 28.5% of submitted and accepted papers, and last authors (FLA) in 16.5% and 22%, respectively. The acceptance rate was 34.7% ( Conclusion: Female authorship is under represented in submitted and published papers in EJVES VF, with important geographical differences. The number and percentage of female reviewers is increasing; their performance is comparable with their male colleagues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.